Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Lonza Group Ltd ( (CH:LONN) ) has provided an announcement.
Lonza Group Ltd has appointed Andreas Bohrer as the Chief Legal & Corporate Affairs Officer, effective July 1, 2025. Andreas, who has been with the company since 2015, will join the Executive Committee and continue to influence Lonza’s strategic direction, particularly in legal, compliance, and public affairs. This appointment reflects his significant contributions, including his leadership during the Covid-19 pandemic, and is expected to strengthen Lonza’s industry positioning and stakeholder relations.
The most recent analyst rating on (CH:LONN) stock is a Buy with a CHF645.00 price target. To see the full list of analyst forecasts on Lonza Group Ltd stock, see the CH:LONN Stock Forecast page.
More about Lonza Group Ltd
Lonza Group Ltd is one of the world’s largest contract development and manufacturing organizations (CDMOs) serving the healthcare industry. With a global presence across five continents, Lonza collaborates with pharmaceutical and biotech companies to transform innovative ideas into viable therapies, focusing on life-saving and life-enhancing treatments. The company reported sales of CHF 6.6 billion and a CORE EBITDA of CHF 1.9 billion for the full year 2024.
Average Trading Volume: 185,888
Current Market Cap: CHF40.35B
See more data about LONN stock on TipRanks’ Stock Analysis page.